Ovogene

What Ovogene does

Ovogene is the world's first AI-driven donor bank, founded in 2017 and operating as a privately held corporation incorporated in Illinois, USA, with medical-directorship operations centered in London, UK. The company provides cryopreserved donor oocytes, sperm, and embryos to fertility clinics and intended parents worldwide, maintaining an inventory of 6,000+ immediately available oocytes drawn from 400+ active donors and processing 20,000+ oocytes annually. Its core platform is the AI Donor Matching System, which analyzes genetic, phenotypic, and medical data to identify optimal donor-recipient matches, complemented by the proprietary Genetically Certified Oocyte® technology that uses deep neural networks for oocyte photo segmentation and morphological screening, and an Electronic Witness System (IVFID-RFID) for sample traceability across partner clinics.

The business operates a hybrid B2B/B2C model: B2B revenue comes from selling biomaterials to 80+ partner clinics across 6 continents with direct-to-clinic delivery, while B2C revenue flows from intended parents using the catalog.ovogenebank.com self-service platform with personal coordinator support. Pricing is quote-based and not publicly disclosed, structured around unit pricing for biomaterials with AI matching services bundled in. The company claims compliance with HFEA, FDA, Canadian ART, EU-Tissue Directive 2004/23/CE, and ANVISA regulations, enabling cross-border biomaterial distribution.

Recent strategic moves include the February 2024 launch of an affiliated clinic (Stem & Gene ART) in Albania, a strategic partnership with Avenues Fertility Clinic including the Ovom patient app, and expansion of representative offices across Eastern Europe, the Mediterranean, and North America. Management is led by founder Dr. Uliana Dorofeyeva (Director of Clinical Operations) and Birol Aydin (Scientific Director), with no disclosed venture capital or private equity backing. Reported clinical outcomes include a 59% first-attempt success rate and 89% cumulative pregnancy rate after the third cycle using donor eggs.

Name

Ovogene

Legal name

Ovogene inc.

Website

https://ovogenebank.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

Ovogene is an AI-driven donor bank supplying cryopreserved donor eggs, sperm, and embryos to 80+ fertility clinics across 6 continents and directly to intended parents worldwide. Founded in 2017, it differentiates through proprietary AI donor matching and morphological screening technology.

Ownership category

akta.pro rank

Product category

Fertility Services

NAICS

Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

Keywords

• Donor egg bank
• AI donor matching
• Fertility biomaterials
• Cryopreservation services
• Reproductive health services

Headquarters

HQ city

Bratislava

Offices9 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Biomaterial Sales: Sale of cryopreserved donor oocytes, sperm, and embryos to fertility clinics and intended parents. The company maintains inventory of frozen biomaterials available for immediate purchase and shipment worldwide.
2. AI Matching Services: AI-powered donor matching system provided as part of the biomaterial selection process.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Ovogene is a donor bank that supplies cryopreserved donor oocytes, sperm, and embryos to fertility clinics and intended parents worldwide. It pairs this biomaterial catalog with an AI Donor Matching System that analyzes genetic, phenotypic, and medical data to recommend donors, supported by extended genetic testing, proprietary Genetically Certified Oocyte® screening, vitrification and storage at -196°C, an Electronic Witness System for sample traceability, and global logistics with regulatory compliance across HFEA, FDA, Canadian ART, EU-Tissue Directive, and ANVISA jurisdictions.

Product overview

Ovogene is the world's first AI-driven donor bank, operating as a unified platform offering egg donors, sperm donors, and frozen donor embryos. The core product is the AI Donor Matching System which processes genetic, phenotypic, and medical data to match recipients with optimal donors. Supporting services include Genetically Certified Oocyte® technology for quality assurance, Extended Genetic Testing, Electronic Witness System (EWS) for traceability, Cryopreservation services, Mitochondrial Donation Program, and Delivery services. The ecosystem also includes a virtual assistant (Genie) and LGBTQ+ family support services. The company provides over 20,000 oocytes per year with 400+ active egg donors, serving clinics across 80+ partners on 6 continents.

Differentiator

Problem solved

Functional benefit

Brands

• Genetically Certified Oocyte® technology: Proprietary technology for NGS oocyte screening and quality certification.

Products and services

• Egg Donor Bank Catalog of cryopreserved and fresh donor oocytes from 400+ active donors across diverse phenotypes and blood groups, offered for immediate purchase for IVF treatments worldwide.
• Sperm Donor Bank Catalog of donor sperm with diverse donor profiles available for direct purchase through the Ovogene online catalog platform for IVF and insemination use.
• Frozen Donor Embryos Gallery of frozen donor embryos available for immediate purchase and embryo creation services for use in IVF and family-building treatments.
• AI Donor Matching System AI-powered matching system that analyzes genetic, phenotypic, and medical data to identify the most suitable egg and sperm donors for recipients in real time, surpassing traditional manual matching accuracy.
• Genetically Certified Oocyte® Technology Proprietary NGS oocyte screening technology using deep neural networks for photo segmentation and morphological analysis, certifying each donor oocyte against Ovogene's quality standards.
• Extended Genetic Testing Comprehensive genetic screening service for donors using NGS-based testing to ensure donors meet rigorous genetic standards before being added to the donor database.
• Cryopreservation Services Long-term vitrification and storage of donor eggs, sperm, and embryos in liquid nitrogen at -196°C with continuous monitoring, data recorders, and temperature tracking for biomaterial integrity.
• Delivery Service Safe and timely worldwide delivery of cryopreserved biomaterials directly to partner fertility clinics, with personalized transport services and real-time tracking.
• Single European Code (SEC) Compliance Service Compliance service providing documentation and traceability for biomaterial transportation within Europe per EU-Tissue Directive 2004/23/CE.
• Electronic Witness System (EWS) IVFID-RFID based electronic witnessing system for IVF procedures featuring RFID smart chips, barcode identification, and real-time data sharing with partner clinics to eliminate sample mix-ups.
• Mitochondrial Donation Program Advanced reproductive service preventing mitochondrial disease transmission from mother to child through maternal spindle transfer (MST) or pronuclear transfer (PNT) integrated into IVF cycles.
• LGBTQ+ Family Services Comprehensive coordinator-led support for LGBTQ+ families covering donor selection, surrogacy guidance, embryo creation in state-of-the-art laboratories, and worldwide biomaterial transportation.

Quantifiable outcome

• 10% improvement in morphological selection accuracy with AI vs manual embryologist selection
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Stem & Gene ART CliniccoreStrategic or Co-development Partner · 5 February 2024Affiliated clinic in Tirana, Albania providing innovative fertility treatments including mitochondrial donation, egg/sperm/embryo donation programs, rejuvenation, and stem cell treatment. The clinic incorporates AI-based clinical security systems and the Electronic Witness System (EWS) to eliminate biomaterial mix-up risks.
• Avenues Fertility CliniccoreStrategic or Co-development Partner · 2 February 2024Strategic partnership with state-of-the-art fertility clinic combining Avenues' commitment to exceptional technologies with Ovogene's reproductive health expertise. Collaboration marks a significant milestone in reproductive care delivery.
• ARKCryominorGTM or Marketing PartnerPartner in Women's Health Check-Up Calendar social project promoting women's well-being and health awareness.
• International Fertility Group (IFG)coreStrategic or Co-development PartnerCollaborative network of fertility specialists and worldwide IVF and surrogacy agency. Ovogene affiliated with Stem & Gene ART Clinic together with IFG. Embryo transfers conducted in Ukraine, Albania, Georgia, Mexico, Slovakia and The Philippines.
• Donors for Life GlobalminorGTM or Marketing PartnerPartner in Women's Health Check-Up Calendar social project promoting women's well-being.
• Fertility Network UKcoreGTM or Marketing PartnerNon-profit organization providing fertility resources and support. Jointly organized webinars including 'How to Achieve Successful Pregnancy After 40' with Dr. Uliana Dorofeyeva. Active collaboration in National Fertility Awareness Week.
• KITAZATOminorOthersAwarded 'Best Practice in Vitrification Recognition 2022' to Ovogene for cryopreservation excellence.
• ESHREminorGTM or Marketing PartnerEuropean Society of Human Reproduction and Embryology. Ovogene team participated in 38th ESHRE Annual Meeting and presented bank updates, rebranding, and new services.
• Red LaraminorGTM or Marketing PartnerLatin American association for assisted reproduction. Ovogene active in Latin American market since 2017 with successful collaborations with clinics in Argentina, Uruguay, Chile, and Brazil. Participated in Red Lara's Congress.

Scale indicators8 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Cryos International: Denmark-based global sperm and egg bank with one of the largest donor pools worldwide. Most directly comparable peer to Ovogene as a multi-country donor bank shipping cryopreserved gametes to fertility clinics and intended parents.
• California Cryobank: Long-established US sperm and egg donor bank with broad donor selection and direct-to-consumer catalog. Direct peer given overlapping product lines (donor eggs, sperm, embryos) and B2B/B2C dual channel model.
• Fairfax Cryobank: US-based sperm donor bank with extensive donor catalog and genetic screening. Comparable to Ovogene on donor-bank inventory model and clinic-direct distribution, though skewed to US market.
• European Sperm Bank: EU-headquartered sperm and egg donor bank serving fertility clinics and private customers across Europe. Direct peer to Ovogene on cross-border gamete distribution under EU-Tissue Directive compliance.
• Donor Egg Bank USA: Network of US fertility clinics pooling frozen donor eggs. Comparable peer as a multi-clinic donor egg distribution platform; less international reach than Ovogene but operates a similar inventory-and-matching proposition.
• The World Egg Bank: US-based egg donor bank focused on frozen donor eggs shipped domestically and internationally. Highly comparable to Ovogene's egg-donor-centric inventory and cryopreservation-led distribution model.
• Xytex Cryo International: International sperm and egg donor bank with global shipping. Comparable on cross-border gamete logistics and clinic partnerships.

Others

• Seattle Sperm Bank:

Emerging players

• Cofertility: US-based fertility platform offering egg-freezing and egg-sharing programs with a tech-forward brand. Emerging peer intersecting Ovogene's space through donor egg access and a digital-first patient experience.
• TMRW Life Sciences: Technology company providing automated cryostorage and IVF specimen management. Adjacent peer relevant to Ovogene's cryopreservation infrastructure and Electronic Witness System roadmap.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCduzzCBc7atXckj40fvWEzg
• Facebookfacebook.com/ovogene.bank
• LinkedInlinkedin.com/company/ovogenebank
• Instagraminstagram.com/ovogene.bank

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ovogene